SARS CoV-2 Reinfection Across a Spectrum of Immunological States
Justine M. McKittrick1, Thomas W. Burke2, Elizabeth Petzold2, Gregory D. Sempowski3, Thomas N. Denny3, Christopher R. Polage, Ephraim L. Tsalik2,4-5, and Micah T. McClain2,4-5
1Duke University School of Medicine, Durham, NC, USA,2Center for Applied Genomics and Precision Medicine, Duke University, Durham, NC, USA,3Duke Human Vaccine Institute, Durham, NC, USA, 4Durham Veterans Affairs Medical Center, Durham, NC, USA, 5Division of Infectious Diseases, Duke University Medical Center, Durham, NC, USA
Key Words : COVID-19; SARS-CoV-2; reinfection; antibody; immunity